← All trials
NCT05444959
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 10, 2021
- Primary completion
- May 10, 2024
- Completion date
- Jul 1, 2024
- First posted
- Jul 6, 2022
- Last posted
- Jul 6, 2022
- Enrollment
- 120
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Poznan UniversityLead sponsor
- Poznan UniversityCollaborator
- Poznan UniversityOverall official - principal investigator
- Poznan UniversityReponsible party - principal investigator
- Charles UniversityCollaborator
- National Science Centre, PolandCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.